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Protocol
AbstrACt
Introduction People with experience of the criminal 
justice system typically have worse physical and mental 
health, lower levels of mental well-being and have less 
healthy lifestyles than the general population. Health 
trainers have worked with offenders in the community 
to provide support for lifestyle change, enhance mental 
well-being and signpost to appropriate services. There has 
been no rigorous evaluation of the effectiveness and cost-
effectiveness of providing such community support. This 
study aims to determine the feasibility and acceptability 
of conducting a randomised trial and delivering a health 
trainer intervention to people receiving community 
supervision in the UK.
Methods and analysis A multicentre, parallel, two-group 
randomised controlled trial recruiting 120 participants 
with 1:1 individual allocation to receive support from a 
health trainer and usual care or usual care alone, with 
mixed methods process evaluation. Participants receive 
community supervision from an offender manager in 
either a Community Rehabilitation Company or the 
National Probation Service. If they have served a custodial 
sentence, then they have to have been released for at 
least 2 months. The supervision period must have at least 
7 months left at recruitment. Participants are interested in 
receiving support to change diet, physical activity, alcohol 
use and smoking and/or improve mental well-being. The 
primary outcome is mental well-being with secondary 
outcomes related to smoking, physical activity, alcohol 
consumption and diet. The primary outcome will inform 
sample size calculations for a definitive trial.
Ethics and dissemination The study has been approved 
by the Health and Care Research Wales Ethics Committee 
(REC reference 16/WA/0171). Dissemination will include 
publication of the intervention development process 
and findings for the stated outcomes, parallel process 
evaluation and economic evaluation in peer-reviewed 
journals. Results will also be disseminated to stakeholders 
and trial participants.
trial registration numbers ISRCTN80475744; Pre-
results.
bACkground 
People with experience of the criminal 
justice system (CJS) have greater physical 
and mental healthcare needs, lower psycho-
logical well-being1 and experience significant 
problems in accessing health and social care 
services2 compared with the general popu-
lation in the UK. Services for those under 
community supervision with multimorbidi-
ties are often fragmented.3 A lack of trust in 
health services and health professionals (eg, 
in primary care) causes many offenders to 
strengths and limitations of this study
 ► The pilot trial has developed comprehensive meth-
ods for a rare study involving offenders under com-
munity supervision across two geographical sites.
 ► The pilot trial employs a tailored health trainer in-
tervention involving one-to-one support to support 
clients with changes in four health behaviours and 
well-being, which are often overlooked in the target 
population.
 ► The trial’s development involved extensive public 
and patient involvement to maximise acceptability 
and feasibility.
 ► The findings will inform if the progression rules are 
met and whether there is a case for extending the 
study into a definitive trial.
 ► The study is not powered to detect changes in the 
quantitative outcomes but instead aims to assess 
acceptability and feasibility of the trial methods and 
intervention. 
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avoid seeking medical help despite a high prevalence of 
emotional problems.4 
Unhealthy behaviours such as problematic alcohol use 
and smoking are much higher in the offender population 
than the general population.5 For example, 60%–80% 
of the offender population report problematic alcohol 
use compared with 20%–30% in the general population 
and around 80% of offenders smoke compared with 
just under 20% in the general population.6 Both these 
behaviours (often coexisting) lead to several health 
problems, and possibly lower levels of mental well-being, 
through a number of plausible processes (eg, economic, 
social and psychological). Substance misuse is also prev-
alent, and services and treatment pathways for offenders 
with heroin (opiate) use disorders are well established7 in 
contrast to those with alcohol and tobacco use disorders.
The Government’s 2004 white paper ‘Choosing health: 
making healthy choices easier’8 introduced a new work-
force called health trainers (HTs), often drawn from the 
communities in which they operate. HTs’ main role is to 
provide one-to-one support to people in disadvantaged 
areas to facilitate health behaviour change. A handbook 
for HTs was developed in 2008 outlining the approach and 
evidence-based techniques (eg, goal setting, self-moni-
toring and creating action plans) that HTs can use to help 
people change their behaviour.9 The core work of HTs 
includes the support of behaviour change such as healthy 
eating, stopping/reducing smoking, increasing physical 
activity and reducing alcohol consumption. Their work 
has been positively rated, but there is still a lack of robust 
evaluation.10
Our rapid review of published and grey literature, and 
contact with probation services leads, revealed that the 
scope of HTs has been extended to prison and probation 
settings with promising findings,11 especially when the 
HT has personal experience of the CJS. While HTs have 
typically focused on supporting health behaviour change, 
there is increasing interest in their role being extended to 
facilitate improvements in mental well-being. Evaluative 
evidence suggests where enhancing mental well-being 
has been the main focus of working with a HT, individ-
uals within the CJS are more likely to attain their planned 
goals.11 In parallel work, a screening and brief interven-
tion for reducing alcohol use in individuals in the crim-
inal justice settings12–14 indicated no additional benefit 
in comparison with feedback on screening and a client 
information sheet,15 suggesting a more client-centred 
intervention with longer engagement may be needed. A 
recent systematic review16 identified 95 randomised trials 
involving offenders both in and out of prison (42 studies 
based in the community) that aimed to assess the effects 
of various interventions on improving health outcomes. 
Fifty-nine studies suggested that the intervention led to 
improvements in mental health, substance use, infec-
tious disease outcomes or modified health service use. 
However, 91 of the studies were assessed as having an 
unclear or high risk of bias and the review highlighted the 
lack of high-quality rigorous research with a population 
that is comparatively under researched. Further rigorous 
research is therefore needed to evaluate the effectiveness 
and cost-effectiveness of an HT-led intervention aimed 
at improving mental well-being and health behaviour 
among people under community supervision and to 
understand the change processes involved.
The recent reorganisation of community supervision 
as part of the ‘Transforming Rehabilitation’ agenda 
created Community Rehabilitation Companies (CRCs) 
and the National Probation Service (NPS). The reforms 
included providing supervision to people released from 
prison with sentences under 1 year (ie, people who were 
previously unsupported). This creates a new opportunity 
to work with this part of the population while they are 
still under supervision. Providing HT support within this 
context could improve engagement with existing health 
promotion services,17 stimulate greater ownership and 
control over health behaviour change and involvement 
in activities to foster enhanced mental well-being.18
There has been increasing interest in subjective mental 
well-being, as a more holistic concept than just an absence 
of mental illness. The following five behaviours (collec-
tively known as ‘The Five Ways to Wellbeing (5WWB)) 
to increase mental capacity and well-being were recom-
mended in the Foresight Report18: connect with others; 
be physically active; take notice of things around you; 
keep learning; and give.
Mental well-being potentially impacts on physical 
health (eg, hypertension and heart disease) and mental 
health (eg, depression, self-harm and substance misuse); 
health behaviours (eg, smoking, alcohol, physical activity 
and diet); employment and productivity; crime; and 
society in other ways.18 While the role of exercise for 
improving mental well-being is clear, changing other 
specific health-related behaviours such as smoking may 
also improve subjective feelings of mental well-being 
for some individuals. Individuals’ patterns of current 
behaviour, motivation to change and potential benefits 
will be idiosyncratic and require a personal analysis.18 
Assessing the benefit of health promotion interventions 
is rarely easy, and mental well-being poses particular 
problems. One method of assessing subjective mental 
well-being is through the Warwick and Edinburgh Mental 
Wellbeing Scale (WEMWBS). The WEMWBS captures 
the two perspectives of mental well-being: (1) the subjec-
tive experience of happiness (affect) and life satisfaction 
(the hedonic perspective); and (2) positive psychological 
functioning, good relationships with others and self-re-
alisation (the eudemonic perspective). The latter, based 
on Self-Determination Theory, includes the capacity 
for self-development, positive relations with others, 
autonomy, self-acceptance and competence19 and, there-
fore, the potential to positively enhance further health 
promoting behaviours.
The WEMWBS has been widely used at a population 
level to assess mental well-being, as well as with individuals 
in specific groups.20–22 Original data obtained from the 
Scottish Prisoner Service showed a mean (SD) WEMWBS 
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score of 43.2 (12.3) (range 14–70), compared with a 
general population score of 51.6 (8.71) for England22 and 
49.9 (8.5) for Scotland.23 Lower scores are associated with 
smoking, lower consumption of fruit and vegetables, high 
alcohol intake and lower socioeconomic status.24
People who receive community supervision from the 
new NPS and CRC services are particularly suitable for 
a high intensity health promotion intervention for four 
reasons: (1) they are often excluded from ‘usual’ health-
care and health and wellbeing-promoting interventions 
due to a combination of access arrangements, lifestyle 
factors and distrust of services; (2) they often have low 
levels of mental well-being and poor health-related 
behaviours and thus the gains of the proposed interven-
tion are potentially high; (3) while under supervision, 
and therefore in a period of sustained mandated contact 
with a service, there is an opportunity to both engage 
such individuals in an intervention and capture follow-up 
data within the context of a rigorous evaluation; and (4) 
being subject to justice supervision can often be a time 
when individuals wish to improve their life circumstances, 
particularly towards the start of sentences or transition 
into the community from prison.
The proposed research will develop and test the feasi-
bility and acceptability of a client-centred intervention 
for individuals receiving community supervision aimed 
at improving mental well-being and other secondary 
outcomes and also the acceptability and feasibility of the 
methods involved in a randomised controlled trial (RCT). 
The pilot trial and parallel process evaluation, described 
here, will further test our assumptions, the intervention, 
and establish a framework for estimating cost-effective-
ness. This protocol paper describes the methods for a 
pilot RCT with parallel process evaluation. For the full 
protocol, see online supplementary file.
Aims and objectives
The aim of the pilot trial is to explore uncertainties about 
the acceptability and feasibility of the trial methods and 
intervention prior to progression to a definitive trial.
MEthods
This protocol is informed by Standard Protocol Items: 
Recommendations for Interventional Trials25 guidance 
for the reporting of clinical trial protocols.
study design
This study employs a parallel two-group randomised 
pilot trial with 1:1 individual participant randomisation 
to either the STRENGTHEN intervention plus standard 
care (intervention) or standard care alone (control) with 
a parallel process evaluation.
Participants are being recruited through CRCs in the 
Southwest and Northwest of the England, and through 
the NPS in the southwest only. CRCs manage cases in 
the community who are categorised as presenting low to 
medium risk of serious harm, and the NPS manage cases 
who present a high risk of serious harm. Participants 
are only being recruited through the NPS at one site to 
test the feasibility and acceptability of recruitment and 
engagement of those classified as presenting a high risk 
of serious harm.
Participant inclusion criteria
Participants must satisfy the following criteria to be 
enrolled in the study: males and females aged 18 years 
or older; receiving community supervision; for prison 
releases, have been in the community for at least 2 months 
following any custodial sentence; have a minimum of 
7 months left to serve of community sentence/supervi-
sion; be willing and able to receive support to improve in 
one or more of the four target health behaviours and/
or improve mental well-being; be willing and able to take 
part in a pilot RCT with follow-up assessments at 3 and 6 
months; and be residing within the geographical areas of 
the study.
Participant exclusion criteria
Participants who meet any of the following criteria at 
the time of identification and screening will be excluded 
from study participation: those who present a serious risk 
of harm to the researchers or intervention practitioners; 
those unable to provide informed consent; and those with 
disrupted lives who may find it difficult from the outset 
to engage in the intervention and follow-up assessments. 
Potential participants who are not able to consent when 
originally approached, but who may regain this capacity 
(eg, due to change in intoxication), will be given a further 
chance to participate.
recruitment settings, procedures and initial approach
There are two participant identification pathways: (1) 
via NPS or CRC; and (2) via community organisations. 
Recruitment will take place in community organisations 
as an attempt to reach those who may not engage regu-
larly with the CRC or NPC.
Potential participants are identified in partnership 
with the CRCs and NPS. Decisions whether to include 
someone, based on their level of risk, will be taken by 
the research team at each site in conjunction with local 
services if needed.
1. A single point of access (SPOA) administrator has 
been identified for both the CRCs and the NPS. 
The SPOA administrator identifies potential partici-
pants from the nDelius record system for all services. 
Offender managers (OMs) of identified individuals 
are consulted for screening of inclusion/exclusion cri-
teria and assessment of risk. On receipt of clearance 
to approach potential participants, OMs ask clients if 
they agree to speak to the site researcher either at their 
next scheduled appointment or via the telephone (de-
pending on the current mode of contact between the 
OM and potential participant within their commu-
nity supervision). On receiving verbal agreement to 
approach, the OM facilitates the researcher making 
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the initial approach either in person, following the 
individual’s routine appointment at CRC/NPS or via 
the telephone. All potential participants are offered 
the opportunity to meet the researcher for the initial 
appointment in a meeting space at CRC/NPS offices. 
Identification of participants through community or-
ganisations involve staff initially approaching potential 
participants to invite them to talk to a researcher about 
the study. On receiving verbal agreement to approach, 
the researcher will make a time and date for a meeting. 
The researcher will explain the study and provide the 
opportunity to ask questions. If the individual express-
es an interest in taking part in the study, the researcher 
progresses with the consent process.
2. Community organisations including drug and alco-
hol rehabilitation centres, hostels and day centres 
will also support initial identification of potential 
participants. The consent form for participants who 
are identified through community organisations re-
quests consent for the researcher to make contact 
with the participant’s OM in order to check that 
they meet the criteria for participation in the study. 
Following positive assessment by the OM, the re-
searcher will contact the participant to make a time 
to conduct the baseline data collection. If the OM 
assesses the participant as not meeting the criteria 
for inclusion in the study, the researcher will make a 
time to explain why the participant is unable to take 
part in the study.
screening, baseline and informed consent
Following the initial approach, if a potential participant 
expresses an interest in taking part in the study, a meeting 
is arranged between the researcher and the potential 
participant where the researcher explains the project in 
more detail. This meeting may take place immediately 
after the initial approach, but the potential participant 
can take longer to consider if they want to take part if 
necessary.
The researcher reads and explains the information in 
the participant information sheet (PIS), including time 
burden, at the initial meeting, showing sensitivity to the 
high levels of often undeclared literacy difficulties in this 
population. The researcher places particular emphasis on 
ensuring that the potential participant fully understands 
the concept and implications of randomisation, the 
voluntary nature of the research and their right to with-
draw at any time without detriment to their care or legal 
rights. Confidentiality arrangements (including reasons 
for breaching confidentiality) and data protection are 
also presented.
Having had the opportunity to discuss their involve-
ment in the study and ask questions about it, potential 
participants are asked if they are:
 ► Willing and able to receive support to improve one 
or more of the four target health behaviours and/
or improve mental well-being if randomised to the 
intervention.
 ► Willing and able to take part in a pilot RCT with 
follow-up assessments at 3 and 6 months.
If a potential participant is unwilling or unable to 
proceed, they are thanked for their time and contribu-
tion, reminded that there are no negative consequences 
of not taking part, and their involvement will end. If a 
potential participant is both willing and able to proceed 
to the trial, the consent form is explained to them 
before both the participant and the researcher sign two 
copies (one retained by the participant and one by the 
researcher). The researcher continues with the baseline 
data collection during this same visit/meeting, checking 
that the participant is happy to proceed or makes a 
further appointment for data collection. In the unusual 
circumstance that the baseline data collection occurs 
more than 2 weeks after initial screening, a rescreening 
will take place prior to baseline data collection.
The researcher delivers the baseline data collection 
assessment using the narrative conversational format 
developed in our previous studies.7 The questions from 
the WEMWBS (the primary outcome) are read out to 
participants in a precise and consistent manner should the 
participant prefer/require this rather than completing 
it themselves (method of completion is recorded). 
Questions from other measures are incorporated into a 
specially constructed flexible script that avoids duplica-
tion of subject matter to minimise disengagement or irri-
tability. As per the consent process, individuals who lack 
capacity on a particular day will be given additional oppor-
tunities to complete the baseline data collection assess-
ment, before being deemed to be ineligible to continue 
participation in the study. This is a particularly important 
allowance when the population of interest often live chal-
lenging lives with competing priorities.
ConfIdEntIAlIty
randomisation
Allocation to intervention or control group uses mini-
misation, with a random element, to ensure balance 
between treatment arms with respect to age, gender and 
recruitment site. Recruitment site is determined by a 
combination of geographic region and the service type: 
(1) Northwest CRC; (2) Southwest CRC; and (3) South-
west NPS. Allocation is achieved by means of a web-based 
system created and maintained by the Peninsula Clinical 
Trials Unit.
Once the participant has completed the screening 
interview and baseline data collection assessment, the 
researcher/administrator accesses the randomisation 
website using a unique username and password. The 
website requires entry of the study site, participant’s initials, 
participant’ s date of birth and gender, before returning 
the participant’s unique randomisation number and allo-
cation (intervention or control) to the trial administrator 
via email. The website confirms that the allocation process 
has been successful but does not display the participant’s 
allocated group at the point of entry to maintain blinding 
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of the research assistants (RAs). The first participant was 
randomised on 18 October 2016.
sAMPlE sIzE
A formal sample size calculation based on considerations 
of power is not appropriate; this pilot study is not powered 
to detect between-group clinically meaningful differences 
in a primary outcome. The aim is to provide robust esti-
mates of the likely rates of recruitment and follow-up, 
as well as to provide estimates of the variability of the 
proposed primary and secondary outcomes to inform 
sample size calculations for the planned definitive trial.
When data from a pilot study are required to estimate 
the SD of a continuous outcome, to maximise efficiency 
in terms of the total sample size across pilot and main 
trials, the recommendation is that a two-group pilot study 
should have follow-up data from at least 70 participants 
(ie, 35 per group).26 When considering binary outcomes, 
a total of at least 120 participants is recommended.26 For 
the pilot RCT (phase 2), we believe that over 3 months, 
and across the two sites, we will be able to approach 
around 330 potential participants. We aim to recruit at 
least 120 participants across the two geographical regions 
(60 per region).
treatments
Control arm
Individuals in the control group will receive treatment 
as usual, which will include support from the CJS and 
any other third sector or healthcare organisations in the 
standard way. For each site, we will identify what support 
participants would normally receive while working with 
the NPS and CRCs, and this will be documented, updated 
and maintained. Participants in both arms of the study 
will have access to all local services as usual.
Intervention arm
Through original research and literature reviews, we 
have developed an extensive understanding of what are 
likely to be the effective components of an intervention 
targeted at health behaviours and improvement of health 
and mental well-being in this population. A clear starting 
point logic model (which will be presented in more detail 
elsewhere) of intervention components and aims under-
pins the intervention, based on the HT role in a previous 
trial of smoking cessation in disadvantaged groups27 and 
the development of a collaborative care model for prison 
leavers with multiple health problems.28 The intervention 
aims to enhance people’s mental well-being and improve 
their health-related behaviours.
The HT role has been adapted for specific populations, 
including offenders11 and smokers,27 with early signs that the 
support is acceptable and feasible. However, further inter-
vention development and piloting was required to integrate 
a focus on promoting mental well-being and multiple health 
behaviour changes in offenders in the new NPS/CRCs 
context and to understand the interactions between mental 
well-being and health behaviour changes. These uncertain-
ties have been explored, and reduced, in a formative process 
evaluation working with the peer researchers, people with 
lived experience of the CJS.
A training package was delivered to the HTs on the 
project focusing on the core competencies of an HT 
as outlined in the HT handbook9 with training in the 
5WWB. During the manualisation phase, the HT hand-
book was adapted to incorporate the principles of 5WWB 
and tailored for working with the target population.
The key components of the intervention are:
1. An HT is available for one-to-one sessions over 14 
weeks, in face-to-face or telephone format (frequen-
cy and length of sessions is negotiated with each par-
ticipant). We expect an average of 4–6 sessions (with 
greatest results being achieved up to six sessions with 
diminishing returns beyond that29). The face-to-face 
intervention sessions take place in a variety of settings, 
including probation services and other local commu-
nity locations. Initial engagement and proactive fol-
low-up is based on our previous offender research.
2. An initial invitation to engage with the HT is described 
as an ‘open and flexible’ opportunity to receive sup-
port for one or more of the target health behaviours 
and/or improving overall health and mental well-be-
ing through other activities including connecting, 
keeping learning, being active, taking notice and giv-
ing (ie, the 5WWB).
3. HTs are trained to help participants understand the 
inter-relationship between health behaviours such as 
smoking, alcohol use, diet, physical activity and their 
relationship to mental well-being and other positive 
and negative behaviours, including substance use. 
Each participant develops a personal plan based on 
individual behaviour change goals and motivation to 
improve mental well-being. Some offenders will have 
positive perceived mental well-being but engage in 
negative behaviours, while others will be as concerned 
about emotional distress. The intervention is intended 
to be flexible enough to support both these extremes.
4. The support is described as ‘open’ to reflect the 
planned underpinning and overlapping influence 
of Self-Determination Theory and the client-centred 
principles of Motivational Interviewing.30 HTs avoid 
giving ‘advice’ and empower clients to confirm the de-
sire for change and develop self-regulatory skills such 
as self-monitoring, setting action plans and reviewing 
progress. The intervention is tailored and led by the 
participants’ needs.
5. The HT, informed by the 5WWB, helps clients to build 
positive behaviours (eg, initiating and maintaining ac-
tivities (physical, creative and so on) and find opportu-
nities for gaining core human needs (ie, sense of com-
petence, autonomy and relatedness), as well as learn 
and notice, to enhance mental well-being.
6. Any reductions in alcohol consumption (as units 
per week, alcohol-free days or avoidance of trigger 
events31), smoking (using different strategies27 32) and 
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increases in physical activity and healthy eating are 
supported, with the aim to build confidence to meet 
guidelines for safe alcohol consumption, to quit/re-
duce smoking, engage in daily/weekly physical activity 
and healthy eating.
7. Participants are actively supported to gain help from 
friends and family, link with other community resourc-
es (parks and leisure centres) and services (eg, Stop 
Smoking Services and Drug and Alcohol Treatment 
Service) as a part of achieving their personal plan, 
exploring options for continued support after the in-
tervention as appropriate. We have found signposting 
alone to be insufficient with this population.27
blIndIng
Blinding of the researchers is being tested for feasibility 
to see whether it would be possible in the definitive trial. 
Researchers record instances where they believe they 
have been unblinded in any way.
outcome measurement
Feasibility outcomes
The study aims to collect data on the following accept-
ability and feasibility outcomes: proportion of eligible 
participants; recruitment rates; rates of attrition and 
loss to follow-up; completion and completeness of data 
collection; estimates of the distribution of outcome 
measures; acceptability of intervention to participants; 
and acceptability of study participation to participants.
Assessments
Data are collected in the following areas as proposed 
outcome measures to be used in a future definitive 
trial and to assist with predicting SD size for future 
sample size calculations: subjective mental well-being 
(WEMWBS)20 21 33 34; self-reported smoking (number of 
cigarettes smoked per day)27; Fagerström Test for Ciga-
rette Dependence35; alcohol use Alcohol Use Disorder 
Identification test (AUDIT-C)36; diet (Dietary Instru-
ment for Nutrition Education)37; physical activity (7-day 
recall of physical activity)38; substance use Treatment 
Outcomes Profile (TOPS)39; confidence, importance, 
access to social support, action planning and self-moni-
toring measures relating to the four health behaviours; 
health-related quality of life (EQ-5D-5L and SF-36); and 
health, social care, criminal justice and voluntary sector 
resource use (see table 1).
dAtA CollECtIon
Process evaluation
A parallel process evaluation is taking place alongside the 
pilot trial.
Aims
The aims of the process evaluation are: (1) to assess 
whether the intervention is being delivered as per 
manual and training; (2) to ascertain components of the 
intervention that are critical to delivery; (3) to explore 
reasons for divergence from delivery of intervention as 
manualised; (4) to understand when context is moder-
ating delivery; (5) to understand the experience and 
motivation of participants in the control arm of the pilot 
to maximise retention in a full trial; (6) to explore reasons 
for declining to participate in the trial; (7) to explore 
reasons for disengaging in the intervention before an 
agreed end; and (8) to understand, from a participant 
perspective, the benefits and disadvantages of taking part 
in the intervention.
Data collection
The mixed methods data collection will include:
Face-to-face semistructured interviews will be conducted 
with:
 ► STRENGTHEN HTs (n=6) across both geographical 
regions.
 ► CRC and NPS staff (n=6) across both geographic 
regions.
 ► Participants who disengaged before an agreed end 
(up to 6).
 ► Participants randomised to the intervention arm of 
the pilot (high and low levels of engagement) (n=6).
 ► Participants randomised to the control arm of the 
pilot (n=6).
All interviews will be digitally audio-recorded and tran-
scribed verbatim.
We will also collect:
 ► Field notes, written by RAs, on potential participants 
reasons for declining to participate in the study, while 
being sensitive to their rights to decline further partic-
ipation without providing a reason.
 ► Digital audio recordings of HT sessions (n=20). 
Consent to record sessions will be sought at the start 
of the intervention and reconfirmed at each session 
prior to recording.
 ► HT session report forms. HTs will keep a record of 
each session, including information on: date, loca-
tion, duration, type (face to face or by telephone), 
subsidy use, primary goals of the participant, goals 
met (if applicable) and any difficulties encountered 
for discussion in supervision.
Analysis
Intervention fidelity will be assessed through the scoring 
of audio recordings of HT sessions against a developed 
list of six key intervention processes: (1) active partici-
pant involvement; (2) motivation building for changing 
a behaviour and improving mental well-being; (3) set 
goals and discuss strategies to make changes; (4) review 
efforts to make changes/problem solving; (5) integration 
of concepts;and (6) engaging social support. These will 
be scored on two domains: practitioner adherence to the 
protocol and competence of delivery.
Quantitative data will be summarised descriptively, 
with CIs as appropriate. Any factors that are identified 
as possibly contributing to participants’ intervention 
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engagement and trial recruitment and retention will 
be explored in more detail in the qualitative data. Data 
from the qualitative sources (eg, interviews and audio 
recordings) will be synthesised into a Framework Anal-
ysis grid supported by NVivo 10 software.40 The deduc-
tively driven components of the framework analysis will 
explore the feasibility and acceptability of the inter-
vention and the research data collection techniques. 
Quantitative and qualitative data will also be compiled 
into case studies for a purposively selected subsample 
of participants to maximise understanding of how the 
intervention is, or is not, working for individuals.41 Any 
procedures that need to be adapted will be identified 
and improvements, and solutions will be identified. 
The size and impact of potential changes will inform a 
decision as to whether this is an internal or an external 
pilot trial prior to progression to a definitive trial.
Contribution
The process evaluation will contribute to the research 
through: (1) revision of the logic model of how we 
understand the intervention to work, development of 
the way in which we deliver the intervention and how 
we should optimise research data collection in a defin-
itive trial; (2) identification of which areas of the inter-
vention are not being delivered as intended to help 
plan for future training and development in a definitive 
trial; (3) generalisable learning about the feasibility and 
acceptability of trial procedures with this population; 
(4) the decision as to whether to progress to a full trial 
Table 1 SPIRIT table study schedule
Baseline assessment
Screening Baseline data Allocation
Timepoint t1 t1 +3 months
T2
+6 
months
T3
Enrolment:
Eligibility screen X
Informed consent X
Allocation X
Interventions:
Intervention group: Strengthen intervention
Usual care
Control group: Usual care
Assessments:
Demographics X
WEMWBS X X X
AUDIT-C X X X
DINE X X X
7-day PA recall X X X
Self-reported smoking X X X
FTCD X X X
Importance, confidence, social support, action 
planning and self-monitoring
X X X
Treatment Outcomes Profile X X X
EQ-5D-5L Questionnaire X X X
SF-36 X X X
Resource use questionnaire X X X
Safety monitoring:
Adverse event reporting
AUDIT-C, Alcohol Use Disorder Identification Test; DINE, Dietary Instrument for Nutrition Education; FTCD, Fagerström Test for Cigarette 
Dependence; PA, physical activity; SF-36, 36-Item Short Form Survey; WEMWBS, Warwick and Edinburgh Mental Wellbeing Scale.
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or not; and (5) the design of the process evaluation for 
a full trial.
statistical analysis
Quantitative
An initial analysis after 6-month follow-up is completed 
will focus on (1) recruitment and retention; and (2) 
adherence to the intervention:
1. A Consolidated Standards of Reporting 
Trials (CONSORT) diagram will provide a detailed de-
scription of numbers approached, meeting eligibility, 
having baseline data collected, being randomised and 
having follow-up data collected.
2. A descriptive analysis will report on the proportions of 
those randomised to the intervention and who attend-
ed two or more sessions, completed all sessions and set 
behaviour change goals in personal plans.
Data from screening, recruitment and follow-up logs 
will be used to generate realistic estimates of eligibility, 
recruitment, consent and follow-up rates in the study 
population to assess the feasibility outcomes of the study. 
We will also estimate completion rates for each of the 
proposed outcome measures at each time-point. All such 
estimates will be accompanied by appropriate confidence 
intervals to allow conservative assumptions to be made 
in the planning of the definitive trial. Individuals lost to 
follow-up will be compared with those who complete the 
pilot study to identify any potential bias.
It is inappropriate to use pilot study data to formally test 
treatment effects, therefore the statistical analyses will be 
of a descriptive nature.42 43 We will follow the CONSORT 
extension for reporting of pilot and feasibility studies43–45 
and take note of the CONSORT extension for reporting 
of patient-reported outcomes.46 Descriptive statistics 
of the proposed primary and secondary outcomes will 
be produced, as appropriate for each measure for each 
group. Interval estimates of the potential intervention 
effects, relative to usual care, will be produced in the form 
of a 95% CI to ensure that the effect size subsequently 
chosen for powering the definitive trial is plausible, but 
no formal hypothesis testing will be undertaken of the 
pilot data.42 Analyses will be on an intention-to-treat basis.
Economic analysis
The pilot study will be used to estimate the resource use 
and costs associated with the delivery of the intervention 
and to develop a framework for estimating the cost-effec-
tiveness of the STRENGTHEN intervention plus usual 
care, versus usual care alone, in a future economic eval-
uation alongside a fully powered RCT. We will develop 
and test economic evaluation methods for the collection 
of resource use data, and for estimating related costs, 
and pilot the collection of outcome data appropriate 
for economic evaluation. In a future full economic eval-
uation, it is anticipated that the primary perspective 
for analyses will be that of the National Health Service 
(NHS) and Social Care Services (ie, third-party payer), 
with a broader participant and societal perspective 
explored in sensitivity analyses, and this will guide the 
development of the methodological framework in the 
pilot study.
The key areas of resource use and costs associated with 
the delivery of the intervention will be identified (eg, 
HT time, training, supervision, travel and consumables), 
and methods will be tested for the collection of these 
data. This will be via within-trial participant level records 
of HT input (including contact time and non-contact 
time). Data on participant health service use, social care 
service use and other broader aspects of resource use 
will be collected using self-report (interviewer adminis-
tered) questionnaires at baseline, 3-month and 6-month 
follow-ups. This resource use questionnaire will be devel-
oped specifically for this participant population, using 
the approach described for the Client Service Receipt 
Inventory47, and based on our experience of collecting 
resource use data in a wide range of prior studies.
A future full economic evaluation will present the 
cost-effectiveness analysis with the incremental cost 
per unit of change on the primary outcome measure 
(expected to be the WEMWBS). The primary economic 
endpoint of policy relevance will be the incremental cost 
per quality-adjusted life year (QALY) gained. QALYs will 
be estimated using participants’ data collected using the 
EQ-5D-5L48 and the recommended value set for England.49 
Given uncertainty associated with estimating QALYs for 
this population, the SF-36, from which the SF-6D can be 
derived,50 will also be used to estimate QALYs in sensi-
tivity analysis. EQ-5D-5L and SF-36 data are collected at 
baseline, 3-month and 6-month follow-ups, and the pilot 
study will assess the feasibility of use and completion rates 
regarding these measures.
A future economic evaluation is expected to include 
extrapolation from the trial outcomes to extend the trial-
based cost-effectiveness analysis over the longer term, 
for example, using 1-year and 2-year time horizons. Such 
mathematical modelling would involve evidence synthesis 
and the use of assumptions, and the pilot study will be used 
to consider these issues in the context of future research. 
In addition, the pilot study data will be described in a 
cost-consequences framework, which presents costs and 
outcomes in a disaggregated, tabular format.51 52
Patient and public involvement
Previous work with the target population, conducted by 
the authors, established peer researcher groups and the 
current study drew on these to help revise and focus the 
research question. In the early stages of this pilot trial, 
two public and patient involvement (PPI) groups (one 
male and one female) were established and informed 
the design of the pilot trial and intervention. They also 
advised on the time, duration and frequency of interven-
tion contacts to ensure an acceptable level of burden. 
The PPI groups helped informed recruitment methods 
to ensure acceptability. PPI representatives form part of 
the trial steering committee to guide the conduct of the 
study.
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A short report will be made available to participants 
at both study sites, as well as disseminated via email and 
social media.
trIAl stAtus
Recruitment was originally due to cease in December 
2016. Due to a delay in securing a second site along with 
a major restructuring of the host organisations (the NPS 
and the CRCs), the recruitment window was extended 
and the final participant was recruited on 7 December 
2017. Data follow-up is ongoing and is planned to be 
completed in June 2018. Decisions concerning progres-
sion to a definitive trial will then take place.
dIsCussIon
The present pilot study aims to reduce uncertainties 
in acceptability and feasibility of the intervention and 
trial methods. The work presents a unique opportunity 
to explore if and how best to recruit traditionally hard-
to-reach participants and follow them up for up to 6 
months. A few small studies that generally lack meth-
odological rigour have been conducted, and this study 
seeks to determine if more robust methods can be used 
and what challenges may be faced and how to overcome 
them. The intervention has been adapted from existing 
service delivery in what appears to be isolated locations. 
The present study involves carefully defining the interven-
tion components and observing how participants engage 
in it, how the manualised intervention is delivered and 
received and whether there are factors that influence 
acceptability and feasibility.
Should the intervention, trial methods and choice 
of outcome measures be shown to be acceptable and 
feasible, and estimates of likely impact on primary and 
secondary outcomes can be produced with some confi-
dence, then support to progress onto a definitive trial 
will be requested. If important changes are needed in 
either the intervention or trial methods, then it will be 
appropriate to make these before further progression to 
a definitive trial. In the first instance, we will describe the 
study as an internal pilot trial, and in the second instance, 
an external pilot trial.
Ethics and dissemination
Dissemination will include publication of the interven-
tion development process and findings for the stated 
outcomes, parallel process evaluation and economic 
evaluation in peer-reviewed journals. Results will also be 
disseminated to stakeholders and trial participants.
national offender Management service (noMs) approvals
The study has been approved by NOMS in conjunction 
with the NHS Research Ethics Committee (REC) proce-
dures. It is a requirement of NOMS that all research 
involving participants under NPS and CRC supervision is 
approved through this process.
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